The crux of maximum hyperemia: the last remaining barrier for routine use of fractional flow reserve.
Nico H J
NH
Pijls
Pim A L
PA
Tonino
D000241:Adenosine / Q000627:therapeutic use*; D058917:Adenosine A2 Receptor Antagonists; D023921:Coronary Stenosis / Q000175:diagnosis*; D003331:Coronary Vessels / Q000473:pathology*; D005260:Female; D053805:Fractional Flow Reserve, Myocardial / Q000187:drug effects*; D006801:Humans; D008297:Male; D011687:Purines; D011720:Pyrazoles; D014665:Vasodilator Agents / Q000627:therapeutic use*
D058917:Adenosine A2 Receptor Antagonists; D011687:Purines; D011720:Pyrazoles; D014665:Vasodilator Agents; C430916:regadenoson; D000241:Adenosine